TSE:OGI - OrganiGram Holdings Inc. (OGI.TO) Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: C$3.43
  • Forecasted Upside: 50.61 %
  • Number of Analysts: 8
  • Breakdown:
  • 0 Sell Ratings
  • 6 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
C$2.28
▼ -0.02 (-0.87%)
1 month | 3 months | 12 months
Get New OrganiGram Holdings Inc. (OGI.TO) Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for OGI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for OGI

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
C$3.43
▲ +50.61% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for OrganiGram Holdings Inc. (OGI.TO) in the last 3 months. The average price target is C$3.43, with a high forecast of C$6.00 and a low forecast of C$2.00. The average price target represents a 50.61% upside from the last price of C$2.28.
Hold
The current consensus among 8 investment analysts is to hold stock in OrganiGram Holdings Inc. (OGI.TO). This rating has held steady since July 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 0 sell ratings
7/28/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 0 sell ratings
10/26/2019
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
1/24/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 0 sell ratings
4/23/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 0 sell ratings
7/22/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 0 sell ratings
10/20/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 5 hold ratings
  • 0 sell ratings
12/19/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 0 sell ratings
1/18/2021

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetDetails
1/13/2021Alliance Global PartnersDowngradeBuy ➝ Neutral
i
Rating by A. Grey at Alliance Global Partners
1/13/2021Canaccord GenuityDowngradeSpeculative Buy ➝ HoldC$2.50 ➝ C$2.00
i
1/13/2021Eight CapitalLower Price TargetC$3.50 ➝ C$2.00
i
1/11/2021Raymond JamesUpgradeMarket Perform ➝ OutperformC$3.00
i
12/8/2020Raymond JamesReiterated RatingMarket PerformC$3.00
i
12/4/2020Jefferies Financial GroupBoost Price TargetC$3.79 ➝ C$3.89
i
12/1/2020CIBCBoost Price TargetC$2.00 ➝ C$2.25
i
12/1/2020Haywood SecuritiesLower Price TargetHoldC$2.50 ➝ C$2.00
i
11/23/2020Raymond JamesLower Price TargetMarket PerformC$5.00 ➝ C$3.00
i
10/1/2020Raymond JamesSet Price TargetMarket PerformC$5.00
i
9/16/2020Cantor FitzgeraldBoost Price TargetC$5.00 ➝ C$5.35
i
8/5/2020Jefferies Financial GroupLower Price TargetC$4.50 ➝ C$3.79
i
7/23/2020Eight CapitalLower Price TargetC$4.00 ➝ C$3.50
i
7/22/2020Raymond JamesSet Price TargetMarket PerformC$5.00
i
7/22/2020ATB CapitalDowngradeOutperform ➝ Sector PerformC$4.10 ➝ C$2.30
i
7/22/2020Canaccord GenuityLower Price TargetC$5.00 ➝ C$3.00
i
7/22/2020CIBCLower Price TargetC$2.75 ➝ C$2.00
i
7/22/2020CormarkLower Price TargetC$3.50 ➝ C$2.25
i
7/21/2020Pi FinancialReiterated RatingBuy
i
Rating by J. Zandberg at Pi Financial
7/21/2020AltaCorp CapitalDowngradeOutperform ➝ Sector Perform
i
Rating by D. Kideckel at AltaCorp Capital
7/7/2020Alliance Global PartnersReiterated RatingBuyC$4.00
i
Rating by A. Grey at Alliance Global Partners
7/6/2020Jefferies Financial GroupLower Price TargetC$5.00 ➝ C$4.50
i
6/29/2020Raymond JamesDowngradeOutperform ➝ Market PerformC$6.50 ➝ C$5.00
i
6/1/2020Raymond JamesSet Price TargetOutperformC$6.50
i
5/17/2020Raymond JamesSet Price TargetOutperformC$6.50
i
4/23/2020Raymond JamesSet Price TargetOutperformC$6.50
i
4/16/2020Jefferies Financial GroupLower Price TargetC$5.50 ➝ C$5.00
i
4/15/2020Canaccord GenuityLower Price TargetC$6.50 ➝ C$5.00
i
4/15/2020CIBCDowngradeOutperform ➝ NeutralC$5.00 ➝ C$2.75
i
4/15/2020Haywood SecuritiesLower Price TargetC$5.50 ➝ C$4.75
i
4/15/2020Pi FinancialLower Price TargetBuyC$7.00 ➝ C$5.50
i
4/15/2020AltaCorp CapitalUpgradeSector Perform ➝ OutperformC$5.50 ➝ C$4.10
i
Rating by D. Kideckel at AltaCorp Capital
4/15/2020Eight CapitalLower Price TargetC$7.00 ➝ C$4.00
i
4/15/2020Stifel NicolausLower Price TargetC$10.00 ➝ C$6.00
i
4/14/2020Raymond JamesLower Price TargetOutperformC$9.00 ➝ C$6.50
i
4/8/2020Raymond JamesSet Price TargetOutperformC$9.00
i
3/24/2020Raymond JamesSet Price TargetOutperformC$9.00
i
1/20/2020Jefferies Financial GroupBoost Price TargetC$5.00 ➝ C$5.50
i
1/16/2020Pi FinancialSet Price TargetBuyC$7.00
i
1/15/2020Raymond JamesSet Price TargetOutperformC$9.00
i
1/10/2020CIBCLower Price TargetC$9.00 ➝ C$5.00
i
1/9/2020Raymond JamesDowngradeOutperform ➝ Market PerformC$9.00
i
1/2/2020Jefferies Financial GroupLower Price TargetC$8.20 ➝ C$5.00
i
11/26/2019AltaCorp CapitalDowngradeOutperform ➝ Sector Perform
i
Rating by D. Kideckel at AltaCorp Capital
11/26/2019CormarkLower Price TargetC$10.00 ➝ C$4.50
i
11/26/2019Haywood SecuritiesLower Price TargetC$8.00 ➝ C$7.50
i
11/26/2019Pi FinancialSet Price TargetBuyC$7.00
i
11/26/2019Raymond JamesSet Price TargetOutperformC$9.00
i
11/25/2019Beacon SecuritiesDowngradeBuy ➝ Hold
i
Rating by R. Stanley at Beacon Securities
11/13/2019Raymond JamesSet Price TargetOutperformC$9.00
i
11/13/2019Canaccord GenuityLower Price TargetC$8.50 ➝ C$7.00
i
11/12/2019AltaCorp CapitalLower Price TargetC$13.15 ➝ C$6.50
i
Rating by D. Kideckel at AltaCorp Capital
11/5/2019Cantor FitzgeraldReiterated RatingOverweight
i
Rating by P. Zuanic at Cantor Fitzgerald
10/11/2019Jefferies Financial GroupUpgradeHold ➝ BuyC$10.50 ➝ C$8.20
i
9/24/2019CIBCSet Price TargetOutperformC$9.00
i
6/2/2019AltaCorp CapitalReiterated RatingOutperform
i
Rating by D. Kideckel at AltaCorp Capital
5/3/2019Jefferies Financial GroupDowngradeBuy ➝ HoldC$10.00 ➝ C$10.50
i
4/17/2019CormarkBoost Price TargetSpeculative BuyC$8.50 ➝ C$10.50
i
4/16/2019Canaccord GenuityBoost Price TargetC$8.50 ➝ C$10.50
i
2/25/2019Jefferies Financial GroupSet Price TargetBuyC$10.00
i
1/29/2019CormarkBoost Price TargetC$5.50 ➝ C$8.50
i
1/29/2019Pi FinancialBoost Price TargetC$8.00 ➝ C$10.00
i
12/19/2018Canaccord GenuityBoost Price TargetBuy ➝ AverageC$6.00 ➝ C$7.50
i
10/16/2018Beacon SecuritiesSet Price TargetBuyC$12.00
i
Rating by R. Stanley at Beacon Securities
3/12/2018Eight CapitalBoost Price TargetC$4.50 ➝ C$7.00
i
3/7/2018Canaccord GenuitySet Price TargetC$5.50
i
10/12/2017Canaccord GenuityBoost Price TargetC$3.10 ➝ C$3.60
i
12/8/2016GMP SecuritiesUpgradeHold ➝ Buy
i
12/8/2016MackieBoost Price TargetC$2.00 ➝ C$4.35
i
7/26/2016MackieReiterated RatingSpeculative BuyC$2.00
i
6/13/2016MackieReiterated RatingSpeculative BuyC$1.50
i
4/1/2016Dundee SecuritiesUpgradeNeutral ➝ Buy
i
Rating by A. Salz at Dundee Securities
(Data available from 1/18/2016 forward)
OrganiGram Holdings Inc. (OGI.TO) logo
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers cannabis flowers, extracts, edibles and oils, beverages, and other cannabis products for adult recreational market under the Edison Reserve, Edison Cannabis Co., ANKR Organics, and Trailblazer brands; and medical cannabis products, including strains, cannabis oils, extracts, edibles, beverages, and vaporizers for the medical market. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.
Read More

Today's Range

Now: C$2.28
C$2.27
C$2.33

50 Day Range

MA: C$1.86
C$1.63
C$2.28

52 Week Range

Now: C$2.28
C$1.35
C$4.41

Volume

180,742 shs

Average Volume

2,712,731 shs

Market Capitalization

C$529.21 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of OrganiGram Holdings Inc. (OGI.TO)?

The following Wall Street analysts have issued reports on OrganiGram Holdings Inc. (OGI.TO) in the last year: Alliance Global Partners, AltaCorp Capital, ATB Capital, Canaccord Genuity, Cantor Fitzgerald, CIBC, Cormark, Eight Capital, Haywood Securities, Jefferies Financial Group Inc., Pi Financial, Raymond James, and Stifel Nicolaus.

What is the current price target for OrganiGram Holdings Inc. (OGI.TO)?

13 Wall Street analysts have set twelve-month price targets for OrganiGram Holdings Inc. (OGI.TO) in the last year. Their average twelve-month price target is C$3.43, suggesting a possible upside of 50.6%. Stifel Nicolaus has the highest price target set, predicting OGI will reach C$6.00 in the next twelve months. Canaccord Genuity has the lowest price target set, forecasting a price of C$2.00 for OrganiGram Holdings Inc. (OGI.TO) in the next year.

What is the current consensus analyst rating for OrganiGram Holdings Inc. (OGI.TO)?

OrganiGram Holdings Inc. (OGI.TO) currently has 6 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in OGI, but not buy more shares or sell existing shares.

What other companies compete with OrganiGram Holdings Inc. (OGI.TO)?

How do I contact OrganiGram Holdings Inc. (OGI.TO)'s investor relations team?

The company's listed phone number is 844-644-4726. The official website for OrganiGram Holdings Inc. (OGI.TO) is www.organigram.ca.